Eli Lilly and Co
NYSE:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
B
|
Boeing Co
LSE:BOE
|
US |
|
Ubisoft Entertainment SA
PAR:UBI
|
FR |
|
S
|
Shoprite Holdings Ltd
JSE:SHP
|
ZA |
|
Visa Inc
NYSE:V
|
US |
|
V
|
Vext Science Inc
CNSX:VEXT
|
CA |
|
S4 Capital PLC
LSE:SFOR
|
UK |
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
Daicel Corp
TSE:4202
|
JP |
|
S
|
Scilex Holding Co
NASDAQ:SCLX
|
US |
|
B
|
Byuksan Corp
KRX:007210
|
KR |
|
E
|
EarthRenew Inc
CNSX:ERTH
|
CA |
|
360 DigiTech Inc
NASDAQ:QFIN
|
CN |
|
M
|
Mondi PLC
F:KYC
|
UK |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 231.74 USD with a low forecast of 858.5 USD and a high forecast of 1 575 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 231.74
USD
According to Wall Street analysts, the average 1-year price target for LLY is 1 231.74 USD with a low forecast of 858.5 USD and a high forecast of 1 575 USD.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 18%.
